Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 24, 2001

View Archived Issues

Study In Twins Points To Role Of Genetic Heart Disease Factors

London Exchange Might Ease Listing Rules For Young Firms

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

European Bioethics Committee Starts Work, Elects President

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

IsoTis Completes Implants Of Autologous Living Bone Tissue

European Pharma Industry Calls For New Evaluation Structure

Other News To Note

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Cerep, Four European Companies Align To Create Compound Library

Genset Subscribes To Celera Products For Genomics Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...